or Login to see your representatives.

Access Candidates' and Representatives' Biographies, Voting Records, Interest Group Ratings, Issue Positions, Public Statements, and Campaign Finances

Simply enter your zip code above to get to all of your candidates and representatives, or enter a name. Then, just click on the person you are interested in, and you can navigate to the categories of information we track for them.

[x] close
Print Track This Candidate

Public Statements

Senator Michael 'Mike' B. Enzi's Public Statements on Drugs

Mike Enzi
Full Name: Michael 'Mike' B. Enzi
Office: U.S. Senate (WY) - Sr, Republican
First Elected: 11/05/1996
Last Elected: 11/04/2008
Next Election: 2014
Gender: Male
Family: Wife: Diana; 3 Children: Amy, Brad, Emily
Birth Date: 02/01/1944
Birth Place: Bremerton, WA
Home City: Gillette, WY
Religion: Presbyterian

Issue



(clear issue)

Keyword Search

Date Title Location
June 26, 2012 Harkin, Enzi Applaud Passage of Bipartisan Food and Drug Administration Safety and Innovation Act Washington, DC
June 26, 2012 Food and Drug Administration Safety and Innovation Act of 2012--Continued Washington, DC
June 18, 2012 Harkin, Enzi, Upton and Waxman Announce Bipartisan Agreement on Food and Drug Administration Safety and Innovation Act Washington, DC
May 31, 2012 Letter to The Honorable Margaret A. Hamburg, M.D., Commissioner, Food and Drug Administration Washington, DC
May 24, 2012 Harkin, Enzi Hail Senate Approval of Bipartisan FDA Safety and Innovation Act Washington, DC
May 24, 2012 Food and Drug Administration Safety and Innovation Act Washington, DC
May 23, 2012 Food and Drug Administration Safety and Innovation Act Washington, DC
May 23, 2012 The Hill - Passing FDA Bill Will Save Lives Unknown
May 23, 2012 Passing FDA Bill Will Save Lives Unknown
May 21, 2012 Food and Drug Administration Safety and Innovation Act--Motion to Proceed Washington, DC
March 29, 2012 Congress Must Act Now on the Food and Drug Administration's User Fees Washington, DC
March 5, 2012 Grassley, Enzi, Hatch, Pitts Seek Details of Discount Drug Program Washington, DC
Feb. 17, 2012 Letter to George Doyle III, President and Chief Operating Officer of Ben Venue Laboratories Washington, DC
Dec. 15, 2011 Enzi: FDA Should Expedite Review of Applications for Drugs in Shortage Washington, DC
Oct. 5, 2011 Letter to The Honorable Kathleen Sebelius U.S. Department of Health and Human Services Washington, DC
June 22, 2011 Sens. Carper and Coburn Lead Bipartisan Legislation to Combat Billions of Dollars in Waste, Fraud and Abuse in Medicare and Medicaid Washington, DC
June 22, 2011 Sens. Carper and Coburn Lead Bipartisan Legislation to Combat Billions of Dollars in Waste, Fraud and Abuse in Medicare and Medicaid Washington, DC
April 21, 2010 Diary Of a Health Care Debate Veteran Unknown
Dec. 15, 2009 Service Members Home Ownership Tax Act Of 2009 - Resumed Washington, DC
Dec. 4, 2009 Service Members Home Ownership Tax Act Of 2009 Washington, DC
April 29, 2009 Hearing of the Senate Committee on Health, Education, Labor and Pensions - The Swine Flu Epidemic: The Public Health and Medical Response Washington, DC
April 2, 2009 Hearing of the Senate Finance Committee - The Nomination of Governor Kathleen Sebelius (D-KS) to be Secretary of Health and Human Services Washington, DC
March 31, 2009 Hearing of the Senate Committe on Health, Education, Labor and Pensions - The Nomination of Governor Kathleen Sebelius to be Secretary of The Department of Health and Human Services Washington, DC
Sept. 9, 2008 Animal Drug User Fee Act Washington, DC
Sept. 8, 2008 Reauthorization of the Animal Drug User Fee Act, H.R. 6432 Washington, DC
Aug. 1, 2008 Enzi Applauds Senate Passage of Critical Animal Drug Legislation Washington, DC
July 30, 2008 Enzi Urges Senate to Act Swiftly on Critical Animal Drug Legislation Washington, DC
June 26, 2008 Hatch, Enzi: Budget Estimate Confirms Biosimilar Bill Will Reduce Long Term Prescription Drug Costs Washington, DC
April 25, 2008 Enzi Works to Stop Federal Raid On Drug-Fighting Money Washington, DC
Jan. 31, 2008 Health Insurance Cards Washington, DC
Sept. 21, 2007 Food and Drug Administration Reform Legislation Washington, DC
Sept. 21, 2007 Bill to Allow FDA Full Oversight, Monitoring of New Drugs Goes to President Washington, DC
Sept. 20, 2007 Food and Drug Administration Amendments Act of 2007 Washington, DC
Aug. 2, 2007 Unanimous- Consent Request--H. R. 2900 Washington, DC
July 25, 2007 Enzi Anti-Tobacco "Health Act" vs. Democrat "Marlboro Protection Act" Washington, DC
May 9, 2007 Prescription Drug User Fee Amendments of 2007 Washington, DC
May 9, 2007 Enzi: Senate Passage of Bipartisan FDA Legislation a "Monumental Victory for Patient Safety" Washington, DC
May 8, 2007 Prescription Drug User Fee Amendments of 2007 Washington, DC
May 8, 2007 Prescription Drug User Fee Amendments of 2007--Continued Washington, DC
May 7, 2007 Senate Moves Toward Passage of Bill to Give FDA Authority, Resources to Ensure Patient Safety Washington, DC
May 7, 2007 Prescription Drug User Fee Amendments of 2007 Washington, DC
May 7, 2007 Enzi: Dorgan Foreign Drug Act a Threat to Public Health if Not Amended Washington, DC
May 3, 2007 Enzi Rejects Amendment to Drug Safety Bill That Would Compromise Drug Safety Washington, DC
May 3, 2007 Prescription Drug User Fee Amendments of 2007 Washington, DC
May 2, 2007 Prescription Drug User Fee Amendments of 2007 Washington, DC
May 2, 2007 Enzi Supports Amendment to Protect Women's Health Washington, DC
May 1, 2007 Prescription Drug User Fee Amendments of 2007--Continued Washington, DC
May 1, 2007 Prescription Drug User Fee Amendments of 2007 Washington, DC
May 1, 2007 Senate Set to Debate Key Drug Safety Bill Washington, DC
April 30, 2007 Prescription Drug User Fee Amendments of 2007 Washington, DC

About Project Vote Smart

Help Us If You Can

Media & Communications

Education

For Candidates

One Common Ground, Philipsburg, MT 59858 Hotline: 888-Vote-Smart (888-868-3762)
All content © 1992 - 2013 Project Vote Smart unless otherwise attributed - Privacy Policy - Legislative demographic data provided by Aristotle International, Inc. Mobile Version

Back to top